サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747718

服薬アドヒアランスの世界市場

Medication Adherence

出版日
ページ情報
英文 177 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
服薬アドヒアランスの世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

服薬アドヒアランスの世界市場は2030年までに75億米ドルに達する

2024年に34億米ドルと推定される服薬アドヒアランスの世界市場は、2024-2030年の分析期間において13.9％のCAGRで成長し、2030年には75億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるハードウェアセントリック服薬アドヒアランスは、CAGR 15.2％を記録し、分析期間終了までに55億米ドルに達すると予測されます。ソフトウェア中心の服薬アドヒアランスセグメントの成長率は、分析期間でCAGR 10.5％と推定されます。

米国市場は9億80万米ドルと推定、中国はCAGR13.0％で成長予測

米国の服薬アドヒアランス市場は、2024年に9億80万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ13.0％と11.8％と予測されています。欧州では、ドイツがCAGR 10.0%で成長すると予測されています。

世界の服薬アドヒアランス市場- 主要動向と促進要因のまとめ

なぜ服薬アドヒアランスが患者の転帰とヘルスケアシステムの効率性の中心なのか？

服薬アドヒアランスとは、患者が処方された薬物療法を正しく守る度合いであり、特に高血圧、糖尿病、喘息、心血管疾患などの慢性疾患において、治療の成功を決定付ける重要な要素です。服薬アドヒアランスの欠如は依然として広範な問題であり、回避可能な入院、疾患の進行、ヘルスケアコストの増大につながっています。ヘルスケアシステムがバリューベースケアとアウトカムベースの償還にシフトする中、アドヒアランスの改善は臨床的にも経済的にも必須となってきています。

患者は、忘れっぽさ、複雑な投与スケジュール、コストの障壁、副作用、薬の重要性の理解不足などの要因により、服薬アドヒアランスを維持できないことがあります。服薬アドヒアランスの低下は、個人の健康状態に影響を及ぼすだけでなく、臨床試験データを歪め、製薬企業の投資収益率を低下させます。その結果、アドヒアランス向上技術、行動介入、スマートなパッケージングに対する需要は、ヘルスケアのエコシステム全体で勢いを増しています。

デジタルツールと行動モデルはどのようにアドヒアランス戦略を変革しているのでしょうか？

デジタルヘルス技術は、服薬アドヒアランスにおけるイノベーションの最前線にあります。スマートな錠剤ボトル、モバイルアプリ、摂取可能なセンサー、接続されたブリスターパックは、リアルタイムのリマインダー、使用状況の追跡、自動リフィルアラートを提供します。AIを搭載した服薬アドヒアランスプラットフォームは、患者の行動パターンを分析し、パーソナライズされたナッジ、リスク層別化、ゲーミフィケーションや遠隔医療サポートによるエンゲージメントを提供します。電子カルテ（EHR）との統合により、医療提供者は服薬アドヒアランスを監視し、服薬アドヒアランスの欠如を示すパターンがあれば、積極的に介入することができます。

行動経済学と患者中心のデザインは、アドヒアランスソリューションの開発に影響を与えています。現在では、動機付け面接、薬剤師主導のカウンセリング、一貫した服薬を強化する報奨システムなどが介入手段に含まれています。さらに、デジタルセラピューティクス（DTx）プラットフォームは、アドヒアランスの追跡を疾患管理プログラムに組み込んでいます。こうしたアプローチにより、アドヒアランスの範囲はリマインダーだけでなく、個々の患者のプロファイルに合わせた総合的なサポートにまで広がっています。

アドヒアランスに焦点を当てた市場を牽引している利害関係者と治療法は？

慢性疾患管理はアドヒアランスに最も敏感な分野であり、支払者、医療提供者、製薬会社はいずれもアドヒアランスのギャップを埋めるソリューションに投資しています。ポリファーマシー患者、特に高齢者や合併症を持つ患者は、多剤併用アドヒアランスプラットフォームの主要な受益者です。関節リウマチや多発性硬化症に対する生物学的製剤のような特殊療法は、コスト、注射疲れ、症状緩和の遅れなどのためにアドヒアランスに特有の課題を抱えており、そのために支援システムをカスタマイズする必要があります。

製薬会社は、薬剤の有効性と患者の満足度を向上させるために、アドヒアランス技術をコンパニオンアプリやサポートプログラムに組み込んでいます。保険会社や薬局給付管理（PBM）はアドヒアランス分析を導入し、リスクの高い人々をターゲットにして、病院の再入院を減らしています。公衆衛生機関も、特にアドヒアランスが地域社会の健康アウトカムに大きな影響を与える感染症や予防医療キャンペーンに関与しています。

服薬アドヒアランス市場の成長はいくつかの要因によってもたらされる...

服薬アドヒアランス市場の成長は、慢性疾患の世界の負担の増加、価値に基づくケアの重視の高まり、コネクテッドヘルス技術の急速な進歩によってもたらされます。主な促進要因は、リアルタイムのアドヒアランス追跡と報告を促進するスマート投薬パッケージとモバイル対応リマインダーツールの普及です。服薬アドヒアランスデータと臨床判断支援システムとの統合は、的を絞った介入とケア連携の改善を可能にします。

デジタルヘルスソリューションに対する規制当局の支援、回避可能な治療費の削減に対する支払者の関心の高まり、個別化医療の利用拡大が需要をさらに拡大しています。また、製薬業界が実際の薬効と患者維持率の向上に関心を寄せていることも、成長を後押ししています。ヘルスケアがデータ主導型になるにつれ、アドヒアランスプラットフォームは、多様な医療システムにおいて治療成績と業務効率の両方を向上させる上で重要な役割を果たすでしょう。

セグメント

タイプ（ハードウェア中心、ソフトウェア中心）、用途（循環器、中枢神経系、糖尿病、腫瘍、消化器、筋骨格系、その他の用途）

調査対象企業の例（注目の33社）

  • AdhereHealth
  • AdhereTech
  • AllazoHealth
  • Amazon Pharmacy（PillPack）
  • Cardinal Health
  • Cureatr
  • DrFirst
  • Everwell Health Solutions
  • Express Scripts
  • InhandPlus
  • Johnson & Johnson
  • Kinsa
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medisafe
  • MedMinder Systems, Inc.
  • Omnicell, Inc.
  • PatientsLikeMe
  • Philips Healthcare
  • Wellth

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP35340

Global Medication Adherence Market to Reach US$7.5 Billion by 2030

The global market for Medication Adherence estimated at US$3.4 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Hardware Centric Medication Adherence, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Software Centric Medication Adherence segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$900.8 Million While China is Forecast to Grow at 13.0% CAGR

The Medication Adherence market in the U.S. is estimated at US$900.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.0% CAGR.

Global Medication Adherence Market - Key Trends & Drivers Summarized

Why Is Medication Adherence Central to Patient Outcomes and Healthcare System Efficiency?

Medication adherence-the degree to which patients correctly follow prescribed medication regimens-is a critical determinant of treatment success, particularly for chronic conditions such as hypertension, diabetes, asthma, and cardiovascular disease. Non-adherence remains a widespread issue, leading to avoidable hospitalizations, disease progression, and increased healthcare costs. As healthcare systems shift toward value-based care and outcomes-based reimbursement, improving adherence is becoming both a clinical and economic imperative.

Patients may fail to adhere due to factors including forgetfulness, complex dosing schedules, cost barriers, side effects, or lack of understanding of the medication’s importance. Poor adherence affects not only individual health outcomes but also skews clinical trial data and reduces return on investment for pharmaceutical companies. Consequently, the demand for adherence-enhancing technologies, behavioral interventions, and smart packaging is gaining momentum across the healthcare ecosystem.

How Are Digital Tools and Behavioral Models Revolutionizing Adherence Strategies?

Digital health technologies are at the forefront of innovation in medication adherence. Smart pill bottles, mobile apps, ingestible sensors, and connected blister packs provide real-time reminders, usage tracking, and automated refill alerts. AI-powered adherence platforms analyze patient behavior patterns to deliver personalized nudges, risk stratification, and engagement through gamification or telehealth support. Integration with electronic health records (EHRs) enables providers to monitor adherence and intervene proactively when patterns indicate non-compliance.

Behavioral economics and patient-centric design are influencing the development of adherence solutions. Interventions now include motivational interviewing, pharmacist-led counseling, and reward systems that reinforce consistent medication use. Additionally, digital therapeutics (DTx) platforms are embedding adherence tracking into disease management programs-especially for mental health, oncology, and cardiometabolic conditions. These approaches are expanding the scope of adherence beyond reminders to include holistic support tailored to individual patient profiles.

Which Stakeholders and Therapies Are Driving Market Focus on Adherence?

Chronic disease management is the most adherence-sensitive segment, with payers, providers, and pharmaceutical companies all investing in solutions to close adherence gaps. Polypharmacy patients-especially the elderly and those with comorbidities-are key beneficiaries of multi-drug adherence platforms. Specialty therapies, such as biologics for rheumatoid arthritis or multiple sclerosis, face unique adherence challenges due to cost, injection fatigue, and delayed symptom relief, prompting tailored support systems.

Pharma companies are incorporating adherence technologies into companion apps and support programs to improve drug effectiveness and patient satisfaction. Insurers and pharmacy benefit managers (PBMs) are deploying adherence analytics to target high-risk populations and reduce hospital readmissions. Public health agencies are also involved, especially in infectious disease and preventive medicine campaigns, where adherence can significantly impact community health outcomes.

The Growth in the Medication Adherence Market Is Driven by Several Factors…

The growth in the medication adherence market is driven by the increasing global burden of chronic diseases, rising emphasis on value-based care, and rapid advancement in connected health technologies. A key driver is the proliferation of smart medication packaging and mobile-enabled reminder tools that promote real-time adherence tracking and reporting. The integration of adherence data with clinical decision support systems is enabling targeted interventions and improved care coordination.

Regulatory support for digital health solutions, increased payer interest in reducing avoidable treatment costs, and expanding use of personalized medicine are further amplifying demand. Growth is also supported by the pharmaceutical industry’s interest in improving real-world drug effectiveness and patient retention. As healthcare becomes more data-driven, adherence platforms will play a vital role in enhancing both therapeutic outcomes and operational efficiency across diverse health systems.

SCOPE OF STUDY:

The report analyzes the Medication Adherence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hardware Centric, Software Centric); Application (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • AdhereHealth
  • AdhereTech
  • AllazoHealth
  • Amazon Pharmacy (PillPack)
  • Cardinal Health
  • Cureatr
  • DrFirst
  • Everwell Health Solutions
  • Express Scripts
  • InhandPlus
  • Johnson & Johnson
  • Kinsa
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medisafe
  • MedMinder Systems, Inc.
  • Omnicell, Inc.
  • PatientsLikeMe
  • Philips Healthcare
  • Wellth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Medication Adherence - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Globally Drives Demand for Scalable Medication Adherence Solutions
    • Integration of Digital Health Tools and Mobile Apps Strengthens Patient Engagement in Daily Medication Management
    • Growth in Remote Patient Monitoring and Virtual Care Platforms Supports Real-Time Adherence Tracking Capabilities
    • OEM Development of Smart Pill Dispensers and Connected Inhalers Enhances Reminder and Dosing Accuracy
    • Payers and Providers Prioritize Value-Based Care Models That Tie Reimbursement to Medication Adherence Outcomes
    • Use of AI and Predictive Analytics Enables Early Detection of Non-Adherence and Tailored Intervention Strategies
    • Expansion of SMS, App-Based, and Voice-Activated Reminders Improves Access to Low-Cost Adherence Support Tools
    • Pharmacy-Led Adherence Programs and Medication Synchronization Services Increase Patient Refill Compliance
    • Increased Use of Unit-Dose and Pre-Packaged Medication Formats Simplifies Administration and Boosts Adherence in Seniors
    • Inclusion of Behavioral Nudges and Gamification Features Encourages Higher Participation in Digital Adherence Platforms
    • Integration of Medication Adherence Data Into EHRs and Care Management Tools Improves Clinical Decision Support
    • Growth in At-Home Infusion and Specialty Drug Delivery Fuels Need for Adherence Monitoring in Complex Regimens
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medication Adherence Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medication Adherence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medication Adherence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medication Adherence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hardware Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hardware Centric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Software Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Software Centric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Central Nervous System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Medication Adherence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Medication Adherence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Medication Adherence by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION